VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Nov 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-11-17

Reporting Person: Pace Megan E (SVP, Corp. Communications)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-17	Common Stock	S	33	$111.93	Disposed	43350	Direct

Footnotes

F1: Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.